National Recognition for UNIVEN Academic as Dr Bumani Manganye Joins SAHPRA Board

The University of Venda (UNIVEN) has congratulated Dr Bumani Solomon Manganye, Senior Lecturer and Postgraduate Coordinator in the Department of Public Health within the Faculty of Health Sciences, on his appointment to the Board of the South African Health Products Regulatory Authority (SAHPRA) from June 2026 to June 2030. His appointment marks a significant professional milestone and underscores the University’s growing contribution to national leadership in healthcare and public policy.

Dr Manganye’s appointment is a testament to his expertise, leadership and commitment to advancing public health in South Africa. It also reflects UNIVEN’s reputation for producing academics whose knowledge and research continue to influence national development.

SAHPRA is the country’s regulatory authority responsible for safeguarding public health by overseeing the registration and regulation of medicines, medical devices, in vitro diagnostics, complementary medicines, vaccines and other health products. The Authority ensures that these products meet internationally recognised standards of quality, safety, efficacy and performance before they reach the public. Serving on the SAHPRA Board requires individuals of exceptional professional competence, sound ethical judgement and a thorough understanding of healthcare systems and public policy.

For UNIVEN, Dr Manganye’s appointment represents more than individual recognition. It affirms the calibre of expertise within the University and highlights its growing role in shaping national health governance. His selection reflects confidence in the institution’s ability to contribute meaningfully to policy development and the strengthening of South Africa’s healthcare system. The appointment is also expected to create new opportunities for collaboration between the University and national health institutions. These include prospects for joint research, policy engagement, capacity-building initiatives and knowledge-sharing programmes that will benefit both academics and students. It further positions UNIVEN researchers to contribute more actively to discussions on medicine regulation, pharmaceutical policy, health technologies and healthcare innovation.

Dr Manganye’s involvement in national regulatory processes is expected to enrich the University’s academic environment by bringing practical insights into teaching, postgraduate supervision, curriculum development and research. Students in public health, pharmacy, nursing and other health-related disciplines will benefit from exposure to contemporary regulatory challenges and the practical implementation of national health policy.

The appointment also strengthens the University’s research agenda at a time when healthcare is increasingly shaped by technological advances, digital health, artificial intelligence and innovative medical products. Dr Manganye’s new role presents opportunities to promote multidisciplinary research that responds to emerging healthcare challenges while supporting evidence-based regulation and innovation.

Beyond research and teaching, the appointment expands UNIVEN’s professional networks. Through his service on the SAHPRA Board, Dr Manganye will engage with leading healthcare professionals, scientists, researchers, policymakers and regulatory experts from South Africa and abroad. These connections have the potential to foster strategic partnerships, collaborative research, staff development initiatives, student exchange opportunities and access to external research funding.

His achievement also serves as an inspiration to aspiring healthcare professionals and young researchers. It demonstrates that dedication, ethical leadership, continuous learning and academic excellence can open doors to influential national leadership roles that shape the country’s healthcare landscape.

The appointment aligns with the University of Venda’s commitment to producing graduates and academics who respond to societal challenges through quality teaching, impactful research and meaningful community engagement. It extends the University’s contribution beyond the lecture room into national health governance and policy.
As South Africa continues to strengthen its healthcare system and improve access to safe, effective and quality health products, the role of experienced professionals in regulatory institutions remains critical. Dr Manganye’s expertise is expected to support SAHPRA’s mandate while creating new opportunities for UNIVEN to expand its influence in health policy, research, innovation and professional development.

Acting Vice-Chancellor and Principal, Professor Fhulufhelo Netswera, congratulated Dr Manganye on his prestigious appointment, describing it as a proud achievement for both the academic and the University. “Dr Manganye’s appointment reflects the quality of scholarship and leadership cultivated at the University of Venda. We are confident that his expertise and commitment to public service will make a meaningful contribution to strengthening South Africa’s health regulatory system while further enhancing the University’s reputation as an institution committed to excellence, innovation and societal impact,” said Professor Netswera.

As Dr Manganye assumes this important national responsibility, the University remains confident that his leadership and expertise will contribute significantly to advancing public health and strengthening healthcare regulation in South Africa.

Issued by:
Department of Marketing, Branding & Communication University Of Venda
Tel: 082 868 2218 / 082 868 1811